OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Prognostic value of inflammatory and nutritional indexes among advanced NSCLC patients receiving PD ‐1 inhibitor therapy
Qiyu Fang, Jia Yu, Wei Li, et al.
Clinical and Experimental Pharmacology and Physiology (2022) Vol. 50, Iss. 2, pp. 178-190
Open Access | Times Cited: 22
Qiyu Fang, Jia Yu, Wei Li, et al.
Clinical and Experimental Pharmacology and Physiology (2022) Vol. 50, Iss. 2, pp. 178-190
Open Access | Times Cited: 22
Showing 22 citing articles:
Effect of Cancer-Related Cachexia and Associated Changes in Nutritional Status, Inflammatory Status, and Muscle Mass on Immunotherapy Efficacy and Survival in Patients with Advanced Non-Small Cell Lung Cancer
Clelia Madeddu, Sı́lvia Busquets, Clelia Donisi, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1076-1076
Open Access | Times Cited: 29
Clelia Madeddu, Sı́lvia Busquets, Clelia Donisi, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1076-1076
Open Access | Times Cited: 29
Soluble biomarkers to predict clinical outcomes in non-small cell lung cancer treated by immune checkpoints inhibitors
Julien Ancel, Valérian Dormoy, Béatrice Nawrocki‐Raby, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Julien Ancel, Valérian Dormoy, Béatrice Nawrocki‐Raby, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Systemic Immune-Inflammation Index as a Predictor of Survival in Non-Small Cell Lung Cancer Patients Undergoing Immune Checkpoint Inhibition: A Systematic Review and Meta-Analysis
Ye Zhang, Yeye Chen, Chao Guo, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104669-104669
Closed Access
Ye Zhang, Yeye Chen, Chao Guo, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104669-104669
Closed Access
Identification and validation of prognostic biomarkers related to tumor immune invasion in pancreatic cancer
Minxue Chen, Xinyuan Zhou, Yong Fan, et al.
Frontiers in Genetics (2025) Vol. 16
Open Access
Minxue Chen, Xinyuan Zhou, Yong Fan, et al.
Frontiers in Genetics (2025) Vol. 16
Open Access
Inflammatory cytokine profile in non-small cell lung Cancer (NSCLC) patients during early enhanced recovery after surgery (ERAS) period and its relation to hospital length of stay
Yongxia Song, Chun Li, Yan Fang, et al.
Cytokine (2025) Vol. 190, pp. 156918-156918
Closed Access
Yongxia Song, Chun Li, Yan Fang, et al.
Cytokine (2025) Vol. 190, pp. 156918-156918
Closed Access
Nutritional conditions and PFS and OS in cancer immunotherapy: the MOUSEION-010 meta-analysis
Elsa Vitale, Lorenza Maistrello, Alessandro Rizzo, et al.
Immunotherapy (2025), pp. 1-13
Closed Access
Elsa Vitale, Lorenza Maistrello, Alessandro Rizzo, et al.
Immunotherapy (2025), pp. 1-13
Closed Access
CBNPC avancés présentant un contrôle prolongé sous immunothérapie : Cohorte BREATH
S. Deslais, Cassandra Pierre, T. Goter, et al.
Revue des Maladies Respiratoires (2025)
Closed Access
S. Deslais, Cassandra Pierre, T. Goter, et al.
Revue des Maladies Respiratoires (2025)
Closed Access
Prognostic value of combined nutritional and inflammatory markers in NSCLC patients receiving ICIs
Jianying Liu, Jiaxin Liu, Haiyan Chen, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Jianying Liu, Jiaxin Liu, Haiyan Chen, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Identification of prognostic nutritional index as a reliable prognostic indicator for advanced lung cancer patients receiving immune checkpoint inhibitors
Xuebing Yan, Jiaxin Wang, Jingxian Mao, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 9
Xuebing Yan, Jiaxin Wang, Jingxian Mao, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 9
Prognostic Role of Pretreatment Prognostic Nutritional Index in Advanced Lung Cancer Patients Receiving First-Line Immunotherapy: A Meta-Analysis
Junrong Yang, Hui Li, Liangqin Li, et al.
Cureus (2024)
Open Access | Times Cited: 2
Junrong Yang, Hui Li, Liangqin Li, et al.
Cureus (2024)
Open Access | Times Cited: 2
Tertiary lymphoid structures combined with biomarkers of inflammation are associated with the efficacy of neoadjuvant immunochemotherapy in resectable non‐small cell lung cancer: A retrospective study
Fuhao Xu, He Zhu, Dali Xiong, et al.
Thoracic Cancer (2023) Vol. 15, Iss. 2, pp. 172-181
Open Access | Times Cited: 6
Fuhao Xu, He Zhu, Dali Xiong, et al.
Thoracic Cancer (2023) Vol. 15, Iss. 2, pp. 172-181
Open Access | Times Cited: 6
Identification of C-PLAN index as a novel prognostic predictor for advanced lung cancer patients receiving immune checkpoint inhibitors
Jiaxin Wang, Huaijuan Guo, Jingjing Yang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Jiaxin Wang, Huaijuan Guo, Jingjing Yang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Value of computed tomography radiomics combined with inflammation indices in predicting the efficacy of immunotherapy in patients with locally advanced and metastatic non-small cell lung cancer
Hancheng Shao, Jun Zhu, Liang Shi, et al.
Journal of Thoracic Disease (2024) Vol. 16, Iss. 5, pp. 3213-3227
Open Access | Times Cited: 1
Hancheng Shao, Jun Zhu, Liang Shi, et al.
Journal of Thoracic Disease (2024) Vol. 16, Iss. 5, pp. 3213-3227
Open Access | Times Cited: 1
Clinical predictive factors of the efficacy of immune checkpoint inhibitors and kinase inhibitors in advanced hepatocellular cancer
Yunyun Lu, Yi Lu
Clinical & Translational Oncology (2024)
Open Access | Times Cited: 1
Yunyun Lu, Yi Lu
Clinical & Translational Oncology (2024)
Open Access | Times Cited: 1
Relationship between the combination of platelet count and neutrophil‐lymphocyte ratio and prognosis of patients with advanced non‐small cell lung cancer treated with immune checkpoint inhibitors plus chemotherapy: A retrospective cohort study
S. Kashimura, Miki Takenaka Sato, Takahito Inagaki, et al.
Thoracic Cancer (2024) Vol. 15, Iss. 28, pp. 2049-2060
Open Access | Times Cited: 1
S. Kashimura, Miki Takenaka Sato, Takahito Inagaki, et al.
Thoracic Cancer (2024) Vol. 15, Iss. 28, pp. 2049-2060
Open Access | Times Cited: 1
Prognostic value of the systemic immune-inflammation index in lung cancer patients receiving immune checkpoint inhibitors: A meta-analysis
Yanhui Yang, Ji Li, Yi Wang, et al.
PLoS ONE (2024) Vol. 19, Iss. 11, pp. e0312605-e0312605
Open Access | Times Cited: 1
Yanhui Yang, Ji Li, Yi Wang, et al.
PLoS ONE (2024) Vol. 19, Iss. 11, pp. e0312605-e0312605
Open Access | Times Cited: 1
Prognostic Potential of the Prognostic Nutritional Index in Non-Small Cell Lung Cancer Patients Receiving Pembrolizumab Combination Therapy with Carboplatin and Paclitaxel/Nab-Paclitaxel
Fuyumi Nishihara-Kato, Hisao Imai, Takeshi Tsuda, et al.
Oncology (2023) Vol. 102, Iss. 1, pp. 30-42
Closed Access | Times Cited: 3
Fuyumi Nishihara-Kato, Hisao Imai, Takeshi Tsuda, et al.
Oncology (2023) Vol. 102, Iss. 1, pp. 30-42
Closed Access | Times Cited: 3
Impact of preoperative haemoglobin, albumin, lymphocyte, and platelet score on oral cancer prognosis
Yu Ito, Atsushi ABE, Hiroki Hayashi
Oral Diseases (2024)
Closed Access
Yu Ito, Atsushi ABE, Hiroki Hayashi
Oral Diseases (2024)
Closed Access
Prognostic value of immunotherapy in advanced non-small cell lung cancer based on baseline and dynamic changes in hemoglobin, albumin, and platelets
Hui Su, Chao Yu, Guiming Sun, et al.
Biomolecules and Biomedicine (2024)
Open Access
Hui Su, Chao Yu, Guiming Sun, et al.
Biomolecules and Biomedicine (2024)
Open Access
Revealing the prognostic landscape of hemoglobin, albumin, lymphocyte and platelet score in patients with lung cancer: a meta-analysis
Wenxia Wang, Bi Ren, Haocheng Gou, et al.
Research Square (Research Square) (2024)
Open Access
Wenxia Wang, Bi Ren, Haocheng Gou, et al.
Research Square (Research Square) (2024)
Open Access
The prognostic role of markers of systemic inflammation in patients with metastatic lung cancer receiving immunotherapy: A comprehensive review of the literature
Tanya Zlatanova, Jeliazko Arabadjiev
Pharmacia (2024) Vol. 71, pp. 1-7
Open Access
Tanya Zlatanova, Jeliazko Arabadjiev
Pharmacia (2024) Vol. 71, pp. 1-7
Open Access
The Predictive Value of Combined Nutritional Risk Screening (NRS 2002) and Inflammatory Markers for the Efficacy of Non-Small Cell Lung Cancer (NSCLC) Patients Treated with Immune Checkpoint Inhibitors (ICIs)
Jianying Liu, Jiaxin Liu, Haiyan Chen, et al.
Research Square (Research Square) (2024)
Open Access
Jianying Liu, Jiaxin Liu, Haiyan Chen, et al.
Research Square (Research Square) (2024)
Open Access
INFLAMMATORY MARKERS AS PREDICTORS OF EFFICACY OF BEVACIZUMAB AND TYROSINE KINASE INHIBITORS THERAPY IN METASTATIC NON-SMALL CELL LUNG CANCER PATIENTS
О. І. Vynnychenko, Yuliia Moskalenko
Eastern Ukrainian Medical Journal (2024) Vol. 12, Iss. 4, pp. 1007-1017
Open Access
О. І. Vynnychenko, Yuliia Moskalenko
Eastern Ukrainian Medical Journal (2024) Vol. 12, Iss. 4, pp. 1007-1017
Open Access
